4 results
Not approvedWill not start
To assess impact of high doses vitamin D on tumour histology in breast cancer patients
Approved WMOCompleted
The primary objective of the study is to evaluate the efficacy of aliskiren, valsartan and a combination of both drugs versus placebo in lowering levels of NT-proBNP in stabilized patients post ACS
Approved WMOCompleted
The purpose of this study is to determine whether, in patients with type II diabetes at high risk for cardiovascular and/or renal events, aliskiren at a target dose of 300 mg o.d. compared to placebo, on top of conventional treatment, reduces…
Approved WMOCompleted
To assess the effect of vitamin D supplementation on exacerbation rate in patients with COPD and a vitamin D deficiency.